相关实验视频
Updated: Jun 18, 2025

Oral Health Assessment by Lay Personnel for Older Adults
Published on: February 2, 2020
对老年患者的保护性健康行为和多药学的分析:全国性的队列研究
Zhaoyan Piao1, Kyung Sun Oh2, Euna Han3
1College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, 162-1 Songdo-Dong, Yeonsu-Gu, Incheon, Republic of Korea.
保持健康的体重指数 (BMI) 和避免吸烟与老年人减少多药制药风险有关. 更多的保护性健康行为与多药的可能性较低有关.
科学领域:
- 老年医学 老年医学
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 多药性对老年人来说是一个重大问题,增加了不良健康结果的风险.
- 保护性健康行为可能在缓解多药性中发挥作用.
研究的目的:
- 调查65岁及以上成年人的保护性健康行为和多药学之间的关联.
- 确定特定的健康行为,可以降低多药的风险.
主要方法:
- 利用了2012-2016年全国调查数据 (KNHANES) 和医疗保险索赔.
- 包括3297名65岁以上的成年人;定义多药性为>30处方日,6个月内有5种以上的药物.
- 采用多变量逻辑回归来分析健康行为 (BMI,吸烟,饮酒,行走,独自生活) 和多药性之间的关联,包括按年龄和性别分组分析.
主要成果:
- 体重指数 (BMI) <25 (OR,0.76) 和从未吸烟 (OR,0.78) 与较低的多药制药风险相关.
- 体重指数<25在男性和女性子组以及65-79岁年龄组中显示出显著的关联.
- 从未吸烟仅在65-79次组中具有意义;在65-79次组中,具有五种保护性行为的参与者具有显著较低的多药性风险 (OR,0.52).
结论:
- 保持健康的BMI和不吸烟等健康行为与老年人多药性疾病风险降低有关.
- 较高的保护性健康行为综合得分与较低的多药性风险相关.
- 以老年为中心的健康行为管理对于防止多药性治疗至关重要.
更多相关视频
11:21Methodology for Establishing a Community-Wide Life Laboratory for Capturing Unobtrusive and Continuous Remote Activity and Health Data
Published on: July 27, 2018
06:52Assessment of Dependence in Activities of Daily Living Among Older Patients in an Acute Care Unit
Published on: September 30, 2020
相关概念视频
Analysis of Population Pharmacokinetic Data
Drug Therapy
Antianxiety Medications
Factors Affecting Drug Response: Overview
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...